无码欧美成人av天堂456软件,大胆日本熟妇XXXX,9277在线观看免费播放,4p三个男人让我爽了一夜

全、新、優(yōu)、品、好四大特點：

凝血酶(凝血因子II)輕鏈抗體品牌 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標準品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。

凝血酶(凝血因子II)輕鏈抗體品牌 英文名稱  Anti-Thrombin light chain

中文名稱  凝血酶(凝血因子II)輕鏈抗體品牌 

別    名 coagulation factor II; prothrombin; F2; Cf-2; Cf2; FII; F 2; coagulation factor II (thrombin); Coagulation factor II; Coagulation factor II precursor; F2; Factor II; Factor-II; Prothrombin; prothrombin B-chain; PT; serine protease; THRB; THRB_HUMAN; Thrombin; Thrombin light chain.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg 0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, Guinea Pig

產(chǎn)品類型   一抗  

研究領(lǐng)域    心 細胞生物 激酶和磷酸酶 合成與降解

蛋白分子量  predicted molecular weight: 4/64kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human Thrombin light chain

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

凝血酶(凝血因子II)輕鏈抗體品牌 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 Thrombin is the final protease in the blood coagulation cascade and serves both pro- and anticoagulant functions through the cleavage of several targets. The ability of thrombin to specifically recognize a wide range of substrates derives from interactions which occur outside of the active site of thrombin. Thrombin possesses two anion binding exosites which mediate many of its interactions with cofactors and substrates, and although many structures of thrombin have been solved, few such interactions have been described in molecular detail. Glycosaminoglycan binding to exosite II of thrombin plays a major role in switching off the procoagulant functions of thrombin by mediating its irreversible inhibition by circulating serpins and by its binding to the endothelial cell surface receptor thrombomodulin.

Function : Thrombin is an active enzyme in the earliest steps of the blood clot formation, generated from its circulating inactive precursor prothrombin. Thrombin is a glycoprotein formed by two peptides chains of 36 and 259 amino acids linked by disulfure bonds. Three important sites have been identified on the surface of the enzyme: The catalytic site that confers to the molecule its serine protease activity, the exosite one responsible for the binding of the substrate (fibrinogen or thrombin receptor) and the exosite two responsible for the binding of antithrombin III and inactivation of thrombin. Gamma Thrombin is a proteolyzed form of Alpha Thrombin. Gamma Thrombin consists of four chains (A, B1, B5, B4) with a disulfide link between the A peptide and the B5 peptide.

Subunit : Heterodimer (named alpha-thrombin) of a light and a heavy chain; disulfide-linked. Forms a heterodimer with SERPINA5.

Subcellular Location : Secreted, extracellular space.

Tissue Specificity : Expressed by the liver and secreted in plasma.

Post-translational modifications : The gamma-carboxyglutamyl residues, which bind calcium ions, result from the carboxylation of glutamyl residues by a microsomal enzyme, the vitamin K-dependent carboxylase. The modified residues are necessary for the calcium-dependent interaction with a negatively charged phospholipid surface, which is essential for the conversion of prothrombin to thrombin.

N-glycosylated. N-glycan heterogeneity at Asn-121: Hex3HexNAc3 (minor), Hex4HexNAc3 (minor) and Hex5HexNAc4 (major). At Asn-143: Hex4HexNAc3 (minor) and Hex5HexNAc4 (major).

DISEASE : Factor II deficiency (FA2D) [MIM:613679]: A very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels. Note=The disease is caused by mutations affecting the gene represented in this entry.

Ischemic stroke (ISCHSTR) [MIM:601367]: A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.

Thrombophilia due to thrombin defect (THPH1) [MIM:188050]: A multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation. Note=The disease is caused by mutations affecting the gene represented in this entry. A common genetic variation in the 3-prime untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis.

Pregnancy loss, recurrent, 2 (RPRGL2) [MIM:614390]: A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.

Similarity : Belongs to the peptidase S1 family.

Contains 1 Gla (gamma-carboxy-glutamate) domain.

Contains 2 kringle domains.

Contains 1 peptidase S1 domain.

Database links : UniProtKB/Swiss-Prot: P00734.2

實驗流程：

正在熱銷的相關(guān)產(chǎn)品：

Anti-Trk B/FITC 熒光素標記酪氨酸激酶B抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Tau protein 微管相關(guān)蛋白(抗原)Multi-class antibodies規(guī)格： 0.5mg

酪氨酸羥化酶抗體 Anti-TY3H/TH 0.1ml

phospho-SYN1(Ser9) 英文名稱： 磷酸化神經(jīng)突觸素1抗體 0.1ml

EMP2 英文名稱： 上皮細胞膜蛋白2抗體 0.1ml

Rhesus antibody Rh Phospho-INPPL1(Tyr986/987) 肌醇聚磷酸鹽磷酸酶樣蛋白1抗體 規(guī)格 0.1ml

Tau protein 微管相關(guān)蛋白(抗原)Multi-class antibodies規(guī)格： 0.5mg

Anti-Phospho-TIF1beta (Ser824)/FITC 熒光素標記磷酸化轉(zhuǎn)錄中介因子Tif1β抗體IgGMulti-class antibodies規(guī)格： 0.2ml

NPY ( Neuropeptide Y) 神經(jīng)肽 Y(抗原)Multi-class antibodies規(guī)格： 0.5mg

磷酸化微管相關(guān)蛋白抗體 Anti-P-Tau protein 0.1ml

phospho-SYN1(Ser62+Ser67) 英文名稱： 磷酸化神經(jīng)突觸素1抗體 0.1ml

phospho-Ephrin B (Tyr316) 英文名稱： 磷酸化Ephrin B抗體 0.1ml

Rhesus antibody Rh Phospho-LKB1(Thr189) 磷酸化絲氨酸/蘇氨酸蛋白激酶抗體 規(guī)格 0.1ml

NPY ( Neuropeptide Y) 神經(jīng)肽 Y(抗原)Multi-class antibodies規(guī)格： 0.5mg

PAX9(Paired box gene 9) 配對盒基因9抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-ATG7 自噬相關(guān)蛋白7抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Phospho-AP2M1 (Thr156) 磷酸化接頭相關(guān)蛋白復合體AP-2μ鏈1抗體 規(guī)格 0.1ml

PSA 1:150 濃縮液 0.1ml 進口分裝

Ube2L6 英文名稱： 泛素載體蛋白L6抗體 0.2ml

Dihydropyrimidinase 英文名稱： 二氫嘧啶抗體 0.2ml

Anti-ATG7 自噬相關(guān)蛋白7抗體Multi-class antibodies規(guī)格： 0.2ml

IL4 Protein Mouse 重組小鼠 IL4 / Ierleukin-4 蛋白 (Q136D, Y139D, His 標簽)

試劑耗材

HA Others H6N4 甲型 H6N4 (A/chicken/HongKong/17/77) 血凝素HA1 (Hemagglutinin) 人細胞裂解液 (陽性對照)

KB人口腔表皮樣癌細胞 KB human oral epidermoid carcinoma cells MEM培養(yǎng)基(GIBCO)+10%FBSRPMI-1640(GIBCO)+10%FBS

CM-H028人淋巴內(nèi)皮細胞完全培養(yǎng)基100mL

人表皮淋巴內(nèi)管皮細胞(HDLEC)(5×105) 人星形膠質(zhì)細胞 Human

CM-H093人顱蓋造骨細胞完全培養(yǎng)基100mL

LILRB1 Others Human 人 LILRB1 / CD85 / ILT2 / ILR1 人細胞裂解液 (陽性對照)

人直腸平滑肌細胞HRSMC

Ca Ski細胞，人小腸頸部表皮樣癌細胞 人癌細胞,ZR75-1細胞 狗間充質(zhì)干細胞-脂肪DMSC-ad

牛腎細胞;MDBK(BVDV-free)

LCN2 Others Human 人 LCN2 / NGAL 人細胞裂解液 (陽性對照)

凝血酶(凝血因子II)輕鏈抗體品牌 IL4 Protein Mouse 重組小鼠 IL4 / Ierleukin-4 蛋白 (Q136D, Y139D, His 標簽)

試劑耗材

HA Others H6N4 甲型 H6N4 (A/chicken/HongKong/17/77) 血凝素HA1 (Hemagglutinin) 人細胞裂解液 (陽性對照)

KB人口腔表皮樣癌細胞 KB human oral epidermoid carcinoma cells MEM培養(yǎng)基(GIBCO)+10%FBSRPMI-1640(GIBCO)+10%FBS

CM-H028人淋巴內(nèi)皮細胞完全培養(yǎng)基100mL

人表皮淋巴內(nèi)管皮細胞(HDLEC)(5×105) 人星形膠質(zhì)細胞 Human

技術(shù)外包服務(wù):

★凝血酶(凝血因子II)輕鏈抗體品牌 分子生物學：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學：基因合成、引物合成、基因測序、載體構(gòu)建等

★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。